Aker BioMarine is opening an new chapter in its history with the acquisition of the krill oil business from Canadian pharmaceutical manufacturer Neptune Technologies & Bioressources.
From now on, the focus is on scaling up and "accelerating growth," Matts Johansen, CEO of Aker BioMarine, told IntraFish.
"We want to be a significantly bigger company in five years time," he said.
The companies announced the $34 million (€29 million) deal on Wednesday, concluding an extended period of "informal" talks.
